A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice

Safinamide is an approved drug for the treatment of motor fluctuations in Parkinson’s disease (PD). Scarce data are available on its use in clinical practice. A group of Spanish movement disorders specialists was convened to review the use of safinamide across different clinical scenarios that may g...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagonabarraga, Javier, Arbelo, José Matías, Grandas, Francisco, Luquin, Maria-Rosario, Martínez Martín, Pablo, Rodríguez-Oroz, Mari Cruz, Valldeoriola, Francesc, Kulisevsky, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139287/
https://www.ncbi.nlm.nih.gov/pubmed/32197462
http://dx.doi.org/10.3390/brainsci10030176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139287/
https://www.ncbi.nlm.nih.gov/pubmed/32197462
http://dx.doi.org/10.3390/brainsci10030176

Ejemplares similares